Modern Management of MPNs: Recent Advances and Future Directions in ET, PV, and MF

Review the latest data and expert guidance to enhance your treatment of essential thrombocythemia, polycythemia vera, and myelofibrosis! This comprehensive CME/CE/CPE-certified program features focused commentaries, an expert analysis module, and downloadable slides.
Srdan Verstovsek, MD, PhD


How will new and forthcoming clinical data change the management of essential thrombocythemia, polycythemia vera, and myelofibrosis? Here’s my take.

Srdan Verstovsek, MD, PhD Released: February 25, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Tina B. Stacy, PharmD, BCOP, CHCP
(404) 425-4474

Supported by educational grants from
Celgene Corporation
Incyte Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?